Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pegfilgrastim”

Showing 20 of 0 results

Not applicableStudy completedNCT02178475
What this trial is testing

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 943
Testing effectiveness (Phase 2)Study completedNCT01106157
What this trial is testing

Reversing Type 1 Diabetes After it is Established

Who this might be right for
Diabetes Mellitus, Type 1
University of Florida 25
Not applicableStudy completedNCT04460079
What this trial is testing

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Who this might be right for
Chemotherapy-induced Neutropenia
Cinnagen 654
Not applicableLooking for participantsNCT07525869
What this trial is testing

An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy

Who this might be right for
Triple-Negative Breast Cancer
Yonsei University 40
Testing effectiveness (Phase 2)UnknownNCT00751894
What this trial is testing

Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)

Who this might be right for
Solid Malignancies
University Hospital, Clermont-Ferrand 30
Early research (Phase 1)Ended earlyNCT05043649
What this trial is testing

Camsirubicin + Pegfilgrastim to Determine MTD in ASTS

Who this might be right for
Advanced Soft-tissue Sarcoma
Monopar Therapeutics 14
Not applicableEnded earlyNCT01541072
What this trial is testing

Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation

Who this might be right for
Non Hodgkin Lymphoma
Centre Leon Berard 34
Testing effectiveness (Phase 2)Study completedNCT04227990
What this trial is testing

Plinabulin iv Solution in Prevention of TAC Induced Neutropenia

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 115
Not applicableStudy completedNCT02527317
What this trial is testing

Dose Dense Chemotherapy With Lipegfilgrastim Support in Early Breast Cancer

Who this might be right for
Breast Cancer
Beaumont Hospital 40
Large-scale testing (Phase 3)UnknownNCT03404752
What this trial is testing

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Who this might be right for
Breast Cancer
Gema Biotech S.A. 120
Not applicableStudy completedNCT00617370
What this trial is testing

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Who this might be right for
Breast CancerAdenocarcinoma of the Breast
Memorial Sloan Kettering Cancer Center 38
Early research (Phase 1)Study completedNCT02385851
What this trial is testing

Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim)

Who this might be right for
Bioequivalence
Coherus Oncology, Inc. 116
Testing effectiveness (Phase 2)Study completedNCT00968253
What this trial is testing

RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia

Who this might be right for
LeukemiaAcute Lymphocytic Leukemia
M.D. Anderson Cancer Center 24
Early research (Phase 1)UnknownNCT01637493
What this trial is testing

Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients

Who this might be right for
Neutropenia
Hangzhou Jiuyuan Gene Engineering Co. Ltd., 24
Testing effectiveness (Phase 2)UnknownNCT00526734
What this trial is testing

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Erasme University Hospital 100
Early research (Phase 1)Study completedNCT03146988
What this trial is testing

Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta

Who this might be right for
Bioequivalence
Gedeon Richter Plc. 150
Not applicableStudy completedNCT03619993
What this trial is testing

Patient Preference for Pegfilgrastim (Neulasta®) Application Forms

Who this might be right for
Non Hodgkin LymphomaBreast Cancer
iOMEDICO AG 404
Testing effectiveness (Phase 2)Study completedNCT00794261
What this trial is testing

Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma

Who this might be right for
LymphomaMyeloma
Centre Leon Berard 150
Early research (Phase 1)Study completedNCT04014062
What this trial is testing

Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Who this might be right for
Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers
Intas Pharmaceuticals, Ltd. 144
Early research (Phase 1)Study completedNCT03206229
What this trial is testing

Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects

Who this might be right for
Healthy Volunteers
Adello Biologics, LLC 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation